| 000 | 01583 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250518052655.0 | ||
| 264 | 0 | _c20201006 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1873-2518 | ||
| 024 | 7 |
_a10.1016/j.vaccine.2019.06.053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInnis, Bruce L | |
| 245 | 0 | 0 |
_aConvening on the influenza human viral challenge model for universal influenza vaccines, Part 2: Methodologic considerations. _h[electronic resource] |
| 260 |
_bVaccine _c08 2019 |
||
| 300 |
_a4830-4834 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aCongresses as Topic |
| 650 | 0 | 4 | _aCross Protection |
| 650 | 0 | 4 | _aHuman Experimentation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _xprevention & control |
| 650 | 0 | 4 | _aLicensure |
| 650 | 0 | 4 | _aLondon |
| 650 | 0 | 4 |
_aPandemics _xprevention & control |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 |
_aVaccination _xadverse effects |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aScorza, Francesco Berlanda | |
| 700 | 1 | _aBlum, Jeremy S | |
| 700 | 1 | _aJain, Varsha K | |
| 700 | 1 | _aAguilar, Anastazia Older | |
| 700 | 1 | _aPost, Diane J | |
| 700 | 1 | _aRoberts, Paul C | |
| 700 | 1 | _aWairagkar, Niteen | |
| 700 | 1 | _aWhite, Janet | |
| 700 | 1 | _aBresee, Joseph | |
| 773 | 0 |
_tVaccine _gvol. 37 _gno. 35 _gp. 4830-4834 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2019.06.053 _zAvailable from publisher's website |
| 999 |
_c29956938 _d29956938 |
||